longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Xtant Med

XTNT

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Current ValuationThe current P/E ratio is -4.52, within the reasonable range, cheaper than 37.84% of the time in the past 5 years, and the industry ranks 32/45, the industry Median -0.28.

-4.52xP/E
$0.36Stock price
$-0.08Earnings per share
-4.52xP/E
Stock price$0.36Earnings per share$-0.08

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
-7.30x
Typical range
-16.03x–44.78x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
017345168

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x20x40x60x80x100x
P/E ratio
Name/Symbol
BLCOUSBausch + Lomb
-35.80x94.03%$6.12B
MMEDUSMiniMed
-17.96x146.72%$5.64B
NEOGUSNeogen
-351.37x316.68%$2.78B
ESTAUSEstablishment Labs
-48.81x30.16%$1.90B
XRAYUSDentsply Sirona
-3.28x113.34%$1.79B
KIDSUSOrthopediatrics
-14.96x27.74%$594.26M
CERSUSCerus
-73.38x56.25%$497.77M
SMTIUSSanara Medtech
-10.07x104.59%$322.41M
OSURUSOraSure Tech
-5.36x29.79%$263.46M
RXSTUSRxSight
-4.23x0.58%$198.40M
SKYAUSSkyAI
-0.20x--$79.14M
TELAUSTela Bio
-1.35x17.47%$55.67M
ZTEKFUSZENTEK LTD
-7.29x--$54.73M
XTNTUSXtant Med
-4.52x477.77%$50.38M
RMTIUSRockwell Medical
-6.68x32.67%$34.98M
NSPRUSInspireMD
-0.61x--$32.25M
RVPUSRetractable Tech
-5.79x--$20.87M
CUPRUSCuprina
-3.90x--$14.08M
LUCYUSInnovative Eyewear
-1.03x--$7.95M
AIDXUS20/20 Biolabs
-0.73x44.74%$5.22M

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.